Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Nuclear Medicine and Biology|January 21, 2012
Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in ratsCleo L Crunelle, Tim C de Wit, Kora de Bruin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 18, 2012
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosisOswald J N Bloemen, Mariken B de Koning, Tobias Gleich, et al.
Journal of Psychopharmacology (Oxford, England)|February 15, 2014
Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosisMariken B De Koning, Oswald Jn Bloemen, Esther DA Van Duin, et al.
Brain, Behavior, and Immunity|April 11, 2021
Human in vivo neuroimaging to detect reprogramming of the cerebral immune response following repeated systemic inflammationAnnemieke M Peters van Ton, Guus P Leijte, Gerben M Franssen, et al.
Psychological Medicine|December 14, 2017
Intact striatal dopaminergic modulation of reward learning and daily-life reward-oriented behavior in first-degree relatives of individuals with psychotic disorderZuzana Kasanova, Jenny Ceccarini, Michael J Frank, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2008
Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancyHenricus G Ruhé, Jan Booij, Henk C v Weert, et al.
Synapse (New York, N.Y.)|April 6, 2011
COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndromeErik Boot, Jan Booij, Janneke R Zinkstok, et al.
Biological Psychiatry|August 14, 2013
Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorderMartijn Figee, Pelle de Koning, Sanne Klaassen, et al.
Neuroimage. Clinical|March 19, 2019
Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An <sup>123</sup>I-FP-CIT SPECT studyMerijn Joling, Chris Vriend, Pieter G H M Raijmakers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2006
No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activityHein J Verberne, Kora de Bruin, Jan B A Habraken, et al.
Pageof 25